Latest Articles
Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer - geneonline.com
Study Explores Impact of Uterine Adenomyosis on Survival Outcomes in Non-Endometrioid Endometrial Cancer geneonline.com
Published: Oct. 14, 2025, 6:39 p.m.
Fertility Preservation Challenges in Endometrioid Cancer Cases - Bioengineer.org
Fertility Preservation Challenges in Endometrioid Cancer Cases Bioengineer.org
Published: Oct. 14, 2025, 5:59 p.m.
Fertility Preservation Challenges in Endometrioid Cancer Cases - BIOENGINEER.ORG
Fertility Preservation Challenges in Endometrioid Cancer Cases BIOENGINEER.ORG
Published: Oct. 14, 2025, 5:59 p.m.
Fertility Preservation Challenges in Endometrioid Cancer Cases - bioengineer.org
Fertility Preservation Challenges in Endometrioid Cancer Cases bioengineer.org
Published: Oct. 14, 2025, 5:59 p.m.
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - Bioengineer.org
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival Bioengineer.org
Published: Oct. 14, 2025, 5:14 p.m.
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - BIOENGINEER.ORG
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival BIOENGINEER.ORG
Published: Oct. 14, 2025, 5:14 p.m.
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival - bioengineer.org
Uterine Adenomyosis Influences Non-Endometrioid Cancer Survival bioengineer.org
Published: Oct. 14, 2025, 5:14 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - Bioengineer.org
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival Bioengineer.org
Published: Oct. 14, 2025, 4:49 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - BIOENGINEER.ORG
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival BIOENGINEER.ORG
Published: Oct. 14, 2025, 4:49 p.m.
Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer - Nature
Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer Nature
Published: Oct. 14, 2025, 4:47 p.m.
Link copied to clipboard!